Glycation and lipid peroxidation in children and adolescents with type 1 diabetes mellitus with and without diabetic complications

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 7, 2009, Pages 635-643

  Kostolanská, Jana ^a   Jakuš, Vladimir ^b   Barák, L'ubomír ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Diabetic complications; Glycation; Lipid peroxidation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FRUCTOSAMINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHEMICAL ANALYSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FRUCTOSAMINE BLOOD LEVEL; GLYCATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; LIPID PEROXIDATION; OXIDATIVE STRESS; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 69949118369     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2009.22.7.635     Document Type: Article

References (33)

1. Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in insulin dependent diabetes mellitus (IDDM) patients. Diagn Pathol 2007; 2: 22.
2. VanderJagt DJ, Harrison JM, Ratliff DM, Hunsaker LA, Vander Jagt DL. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem 2001; 34: 265-270.
3. Bonnefont-Rousselot D, Beaudeux JL, Thérond P, Peynet J, Legrand A, Delattre J. Diabetes mellitus, oxidative stress and advanced glycation endproducts [in French]. Ann Pharm Fr 2004; 62: 147-157. (Pubitemid 38849729)
4. Gillery P. Oxidative stress and protein glycation in diabetes mellitus. Ann Biol Clin (Paris) 2006; 64: 309-314. (Pubitemid 44212913)
5. Fu S, Fu MX, Baynes JW, Thorpe SR, Dean RT. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Biochem J 1998; 330: 233-239. (Pubitemid 28075745)
6. Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant 1997; 12: 255-258. (Pubitemid 27090974)
7. Kalousová M, Zima T, Tesař V, Štípek S. New markers of advanced damage caused by oxidative and carbonyl stress [in Czech]. Sb Lek 2001; 102: 465-472.
8. Martín-Gallán P, Carrascosa A, Gussinyé M, Domínguez C. Changes in oxidant-antioxidant status in young diabetic patients from clinical onset onwards. J Cell Mol Med 2007; 11: 1352-1366.
9. Spiteller G. Are lipid peroxidation processes induced by changes in the cell wall structure and how are these processes connected with diseases? Med Hypotheses 2003; 60: 69-83.
10. Spiteller G. Peroxyl radicals are essential reagents in the oxidation steps of the Maillard reaction leading to generation of advanced glycation end products. Ann NY Acad Sci 2008; 1126: 128-133. (Pubitemid 351589293)
11. Chiarelli F, Verrotti A, Mohn A, Morgese G. The importance of microalbuminuria as an indicator of incipient diabetic nephropadiy: therapeutic implications. Ann Med 1997; 29: 439-445. (Pubitemid 27520572)
12. Mogensen CE. Should ACE inhibitors be used in normotensive micro-albuminuric IDDM? Diabetes Rev Int 1995; 3: 2-6.
13. Galler A, Müller G, Schintzel R, Kratzsch J, Kiess W, Munch G. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and Nε-(carboxymethyl) lysine ELISA. Diabetes Care 2003; 26: 2609-2615. (Pubitemid 37052108)
14. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 1983; 127: 87-95.
15. Jakuš V, Bauerová K, Michalková D, Čársky J. Values of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus. Bratisl Lek Listy 2000; 101: 484-489.
16. 1c. Diab Nutr Metab 2001; 14: 207-277. (Pubitemid 32982519)
17. el-Saadani M, Esterbauer H, el-Sayed M, Goher M, Nassar AY, Jürgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989; 30: 627-630.
18. Sumegová K, Blažíček P, Waczulí ková I, Žitňanová I, Ďuračková Z. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. Acta Biochim Pol 2006; 53: 783-787. (Pubitemid 46090127)
19. Kubánková V, Hendl J. Statistics for Medics [in Czech]. Praha: Avicenum, 1987; pp 278.
20. Abou-Seif MA, Youssef AA. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 2004; 346: 161-170. (Pubitemid 38901047)
21. Ajabnoor MA, Zawawi TH, Marzouki KM, Marzouki ZM. Level of serum fructosamine in Saudi diabetic patients. Acta Diabetol Lat 1990; 27: 105-112. (Pubitemid 20317699)
22. Martínez MT, Pérez F, Calvilián M, Gutierrez-López MD, Serrano-Rios M. Lipoprotein (a) and other risk factors in Chilean children with type I diabetes mellitus [in Spanish]. Rev Med Chil 1994; 122: 1115-1119.
23. Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HGT, Schlingemann RO, Tarnow L, Parving H-H, Stehouwer CDA, van Hinsbergh VWM. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 1999; 48: 2446-2453. (Pubitemid 30395438)
24. Cohen RM, Le Caire TJ, Lindsell CJ, Smith EP, D'Alessio DJ. Relationship of prospective GHb to glycated serum proteins in incident diabetic retinopathy. Implications of the glycation gap for mechanism of risk prediction. Diabetes Care 2008; 31: 151-153.
25. Martín-Gallán P, Carrascosa A, Gussinyé M, Domínguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003; 34: 1563-1574. (Pubitemid 36638716)
26. Merzouk S, Hichami A, Sari A, Madani S, Merzouk H, Yahia Berrouiguet A, Lenoir-Rousseaux JJ, Chabane-Sari N, Khan NA. Impaired oxidant/antioxidant status and LDL fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients. Gen Physiol Biophys 2004; 23: 387-399. (Pubitemid 40352620)
27. Berg TJ, Dahl-Jørgensen K, Torjesen PA, Hanssen KF. Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM. Diabetes Care 1997; 20: 1006-1008. (Pubitemid 27224954)
28. Chiarelli F, Catino M, Tumini S, Cipollone F, Mezzetti A, Vanelli M, Verrotti A. Advanced glycation end products in adolescents and young adults with diabetic angiopathy. Pediatr Nephrol 2000; 14: 841-846. (Pubitemid 30462181)
29. Marra G, Cotroneo P, Pitocco D, Manto A, Di Leo MAS, Ruotolo V, Caputo S, Giardina B, Ghirlanda G, Santini SA. Early Increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 2002; 25: 370-375. (Pubitemid 41079638)
30. Mylona-Karayanni C, Gourgiotis D, Bossios A, Kamper EF. Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link. Pediatr Diabetes 2006; 7: 51-59. (Pubitemid 43732642)
31. Hsu WT, Tsai LY, Lin SK, Hsiao JK, Chen BH. Effects of diabetes duration and glycemic control on free radicals in children with type 1 diabetes mellitus. Ann Clin Lab Sci 2006; 36: 174-178.
32. Inouye M, Hashimoto H, Mio T, Sumino K. Levels of lipid peroxidation product and glycated hemoglobin A1c in the erythrocytes of diabetic patients. Clin Chim Acta 1998; 276: 163-172. (Pubitemid 28403559)
33. Berg TJ, Nourooz-Zadeh J, Wolff SP, Tritschler HJ, Bangstad HJ, Hanssen KF. Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria. Diabetes Care 1998; 21: 1295-1300.